ARTICLE | Finance

Going with the flow

Canaan prepares to invest 30% of its $800M fund in biopharma

July 29, 2017 12:28 AM UTC

As early stage VC rounds continue to grow, Canaan Partners is once again planning to bump up its allocation to biopharma with its new $800 million fund.

Nearly a third of Canaan XI, which closed on July 25, will go to the sector. About 60% will go to IT, and the remainder to digital health and medtech. ...